Sobetirome (GC-1) The dominant search intent for "gc-1 peptide" is to understand what this compound is, its properties, and its potential applications, particularly in relation to thyroid hormone receptors and metabolic effects.PeptideCoupling Reagents · Amino Acids and ... In rat brown adipocytes,GC-1increases Ucp1 mRNA expression and D2 activity stimulated by adrenergic. Many results point to it being a research chemical rather than a commonly available peptide.
Tier 1:
* Entities: GC-1, Sobetirome, Thyroid Hormone Receptor (TR), TRβ
* High-Relevance Phrases: thyromimetic drug, selective agonist, metabolic rate, obesity, fat mass, cholesterol lowering
Tier 2:
* Entities: TRα, TRβ1, TRβ2, rodents, rats, liver disorders, bile acid metabolism, lipid metabolism, hypothyroid rats
* Attributes/Variations: selective signaling, high affinity, EC50, KD values, metabolic syndrome, dyslipidemia, steatosis, hepatocyte proliferation, Ucp1 mRNA, D2 activity, adrenergic, tachycardia, reproductive performance, lactational performance
* Related Concepts: thyroid hormones, white fat, brown fat, collagen peptide, GLP-1
Tier 3:
* Entities: QRX431, KB2115, eprotirome, QRX-431, BLP-NT122, SLC25A22 (GC1)
* Commercial/Awkward Phrases: peptide for sale, bodybuilding, reddit, dosage, side effects, results, peptide program, Biolab Shop, AdooQ, Enzo, Tocris Bioscience, R&D Systems, Axon 4126, Rousselot, Peptan, NextidaGC, Global Labs, GC, 1, a, Gc, Peptides, peptides, peptide, GC1, peptide, GC 1, peptide, PeptideCoupling Reagents, Amino Acids, Protein Kinase Inhibitor, Cyclin-Dependent Kinase Inhibitor, FormylPeptideReceptor, Melanocortin Receptor, GRK, G Protein, Platelet, CAS 211110-63-3, Other Nuclear Receptors, Nuclear Receptor Agonists, GC 1 (4554)
---
GC-1, also widely known as Sobetirome, is a synthetically developed thyromimetic compound that acts as a selective agonist for thyroid hormone receptors (TRs), particularly the TRβ subtype. This selectivity is crucial, as thyroid hormones play a vital role in regulating metabolism, growth, and developmentSobetirome: the past, present and questions about the future. By mimicking the action of thyroid hormones but with a preferential affinity for TRβ, GC-1 offers a targeted approach to influencing metabolic processes without eliciting the broader, potentially undesirable side effects associated with endogenous thyroid hormones. Research has highlighted its potential in addressing conditions like obesity and metabolic syndrome by influencing fat mass and cholesterol levels.
The primary function of GC-1 is to bind to and activate thyroid hormone receptors, specifically TRβ1 and TRβ2, with a higher affinity than TRα receptors.Sobetirome (GC-1) | TRβ Agonist This selective binding is key to its therapeutic potentialGc-1 sobetirome 1500 mcg. Thyroid hormone receptors are nuclear receptors that, upon activation by thyroid hormones or their mimetics like GC-1, regulate gene expression. This regulation impacts a wide array of physiological functions, including energy expenditure, lipid metabolism, and cardiovascular function.作者：JD Baxter·2004·被引用次数：144—Studies in rats, mice and monkeys show thatGC-1lowers cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than ... GC-1's preference for TRβ allows it to modulate these pathways in a more targeted mannerThyroid hormone receptor beta-specific agonist GC-1 .... Studies have shown that GC-1 can increase metabolic rate, leading to a reduction in fat mass without significantly affecting lean mass or heart rate, a common concern with less selective thyromimetics.
The most extensively studied application of GC-1 lies in its potential to combat metabolic disorders. Its ability to increase metabolic rate and promote the conversion of white fat (which stores calories) into brown fat (which burns calories) makes it a promising candidate for weight management. Research in rodents has demonstrated that GC-1 can effectively reduce accumulated fat, prevent steatosis (fatty liver), and lower cholesterol levels. These effects are attributed to its influence on lipid and bile acid metabolism, as well as its ability to induce hepatocyte proliferation.Sobetirome (GC-1) | TRβ Agonist By selectively activating TRβ, GC-1 may offer a therapeutic avenue for individuals suffering from obesity, dyslipidemia, and the broader metabolic syndrome, potentially improving cardiovascular health markers as well.
GC-1 serves as a valuable research tool for scientists investigating the complex roles of thyroid hormone signaling pathwaysNextida GC - Rousselot collagen and gelatin. Its selectivity allows for precise studies into the specific functions of TRβ in various tissues and physiological processes. Beyond metabolic research, GC-1 has been explored for its effects on liver disorders, suggesting a broader therapeutic scope. While its primary applications are still within the research domain, the ongoing investigation into its synthesis and biological effects continues to pave the way for potential clinical applications.GC-1(Sobetirome) is a synthetic thyroid hormone receptor-beta selective agonist extensively studied for its unique biochemical profile, receptor selectivity, ... The development of improved synthesis strategies for GC-1 aims to make this compound more accessible for further study and potential therapeutic development.PeptideCoupling Reagents · Amino Acids and ... In rat brown adipocytes,GC-1increases Ucp1 mRNA expression and D2 activity stimulated by adrenergic.
It is important to distinguish GC-1 (Sobetirome) from other compounds that may share similar nomenclature or general function. While the term "peptide" is sometimes associated with GC-1 due to its use in biochemical research and the presence of related terms in search queries, GC-1 itself is a synthetic small molecule, not a peptide in the traditional sense. Other peptides, such as collagen peptides, are unrelated and serve entirely different biological functions.2015年3月9日—Kevin Phillips, a researcher at Houston Methodist Research Institute, has already done research on the thyroid hormone receptor agonistGC-1... Furthermore, GC-1's specific affinity for TRβ distinguishes it from less selective thyroid hormone receptor agonists or endogenous thyroid hormones, which interact with both TRα and TRβ receptors, potentially leading to a wider range of physiological effects.
In conclusion, GC-1 (Sobetirome) represents a significant advancement in the study of thyroid hormone mimetics. Its selective action on TRβ receptors offers a targeted approach to modulating metabolism, with promising implications for treating obesity, metabolic syndrome, and related conditions. While still largely a subject of preclinical research, its unique biochemical profile and demonstrated effects on fat mass and cholesterol metabolism position it as a compound of considerable scientific interest.
Join the newsletter to receive news, updates, new products and freebies in your inbox.